Detalhe da pesquisa
1.
Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity.
Nat Immunol
; 25(2): 371-372, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38087084
2.
CIS is a potent checkpoint in NK cell-mediated tumor immunity.
Nat Immunol
; 17(7): 816-24, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27213690
3.
Structural basis for SHOC2 modulation of RAS signalling.
Nature
; 609(7926): 400-407, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35768504
4.
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.
Nature
; 594(7863): 418-423, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953400
5.
Dimerization Induced by C-Terminal 14-3-3 Binding Is Sufficient for BRAF Kinase Activation.
Biochemistry
; 59(41): 3982-3992, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970425
6.
Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses.
Biochem J
; 458(2): 395-405, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24354892
7.
Synthetic Multivalent Disulfide-Constrained Peptide Agonists Potentiate Wnt1/ß-Catenin Signaling via LRP6 Coreceptor Clustering.
ACS Chem Biol
; 18(4): 772-784, 2023 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893429
8.
Structure guided studies of the interaction between PTP1B and JAK.
Commun Biol
; 6(1): 641, 2023 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37316570
9.
CD98hc is a target for brain delivery of biotherapeutics.
Nat Commun
; 14(1): 5053, 2023 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37598178
10.
CRAF dimerization with ARAF regulates KRAS-driven tumor growth.
Cell Rep
; 38(6): 110351, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139374
11.
Negative regulation of RAF kinase activity by ATP is overcome by 14-3-3-induced dimerization.
Nat Struct Mol Biol
; 27(2): 134-141, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31988522
12.
Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1.
Cancers (Basel)
; 11(11)2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31683831
13.
Expression and Purification of JAK1 and SOCS1 for Structural and Biochemical Studies.
Methods Mol Biol
; 1725: 267-280, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29322424
14.
The molecular basis of JAK/STAT inhibition by SOCS1.
Nat Commun
; 9(1): 1558, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674694
15.
Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosis.
Sci Adv
; 4(11): eaat3834, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30498775
16.
Author Correction: CD98hc is a target for brain delivery of biotherapeutics.
Nat Commun
; 14(1): 5516, 2023 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679403
17.
Purification of SOCS (Suppressor of Cytokine Signaling) SH2 Domains for Structural and Functional Studies.
Methods Mol Biol
; 1555: 173-182, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28092033
18.
JAK1 Takes a FERM Hold of Type II Cytokine Receptors.
Structure
; 24(6): 840-2, 2016 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27276423
19.
SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.
Nat Struct Mol Biol
; 20(4): 469-76, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23454976